In Saint-Céré in the Lot, 91 people received a bad dosage of this messenger RNA vaccine, details this Tuesday an article in
La Dépêche du Midi
.
“
Out of 238 patients, 91 are likely to have received an insufficient dose of vaccine.
This injection is harmless to health, but their vaccination course may be incomplete, ”
the director of the Saint-Céré hospital center
told
Figaro
.
To discover
Covid-19: instructions for use of self-tests
Read also: Covid-19: would expanding vaccination now penalize priority people?
All those affected by this insufficient injection have been warned, specifies the Occitanie Regional Health Agency.
With its agreement and that of the national drug safety agency and the regional pharmacovigilance center of Toulouse, 91 of the insufficiently vaccinated patients are invited to perform a serology, via a blood test.
“
This analysis will allow precise measurement of the antibody concentration. Depending on the individual results, a new injection will be offered to certain patients, within the usual deadlines ”
, specified the director of the hospital.” Anxious to be "
transparent
", the latter added that "
The caregivers were going to carry out this serology on Wednesday, May 5. Depending on the results, some people may receive three injections.
"
This bad dosage does not present any risk to health
", has also assured the ARS Occitanie.
When preparing the Pfizer / BioNTech vaccine, caregivers dilute the vaccine with a small amount of physiological saline, which can lead to errors and confusion.
Wednesday April 21,
"it is a human error, unintentional, too much dilution which is at the origin of this bad dosage"
, admits the director.
Two precedents in Marne and Hauts-de-Seine
This "
human error
" echoes that committed Tuesday, April 20, at the vaccination center of Epernay, in eastern France. 140 people received a dose of serum, a salt-water solution, rather than the Pfizer / BioNTech vaccine. Likewise, on April 3 in Châtillon, in Hauts-de-Seine, 54 people mistakenly received a dose of physiological serum rather than Pfizer. A figure confirmed in
Figaro
by ARS Île-de-France, which specifies that it was "
immediately alerted
".
These blunders are not dangerous for health but the patients are not immune to the virus, unanimously indicate the ARS.
For each incident, patients were notified by vaccination centers, by telephone and mail.
New vaccination appointments were offered to them.
SEE ALSO - "
This is the only way to get out of it": in Guadeloupe, vaccination is opened to all adults